Related Experiment Video
Updated: May 1, 2026
10:39
3D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache
Published on: June 2, 2014
19.1K
Tackling chronic migraine: current perspectives
1Neurology Department, Raigmore Hospital, Inverness, UK; Universitat Internacional de Catalunya, Barcelona, Spain.
Journal of Pain Research
|April 22, 2014
Summary
Chronic migraine (CM) affects 1%-3% globally, characterized by headaches on 15+ days/month. Effective management involves addressing risk factors, comorbidities, and utilizing treatments like topiramate and cognitive-behavioral therapy.
Area of Science:
- Neurology
- Headache Medicine
Background:
- Chronic migraine (CM) diagnostic criteria have evolved, with the latest revision in the International Classification of Headache Disorders-3 beta.
- CM is defined by headache frequency (≥15 days/month for >3 months) with migraine features (≥8 days/month).
- Concurrent diagnoses of CM and medication-overuse headache are common and require integrated management.
Purpose of the Study:
- To summarize the current understanding of chronic migraine diagnosis, prevalence, risk factors, comorbidities, and management strategies.
- To highlight the impact of CM on quality of life and associated disabilities.
Main Methods:
- Review of diagnostic criteria and epidemiological data for chronic migraine.
- Identification of modifiable risk factors and common comorbidities associated with CM.
- Summary of evidence-based management and treatment options for CM.
Main Results:
- Global prevalence of CM ranges from 1% to 3%, with an annual incidence of 2.5%.
- Modifiable risk factors include medication overuse, obesity, and stress; comorbidities include chronic pain and psychiatric disorders.
- Effective treatments include topiramate, amitriptyline, onabotulinumtoxinA, and cognitive-behavioral therapy.
Conclusions:
- Effective chronic migraine management requires a multi-faceted approach, including risk factor modification and treatment of comorbidities.
- Evidence-based pharmacologic and non-pharmacologic therapies demonstrate efficacy in managing chronic migraine.
- Improved diagnostic criteria and targeted interventions are crucial for reducing the burden of chronic migraine.
Related Concept Videos
01:25Analgesia and Pain Management
3.3K
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
3.3K
01:29Chronic Pancreatitis II: Collaborative Care
563
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
563
01:17Chronic Bowel Disorders: Introduction
900
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
900
01:29Increased Intracranial Pressure ll: Pathophysiology
20
Increased intracranial pressure (ICP) refers to a potentially life-threatening rise in pressure inside the skull. This usually happens when there is a major change in the volume of brain tissue, blood, or cerebrospinal fluid (CSF) — the three components inside the skull. According to the Monro-Kellie doctrine, if the volume of one component increases, the volumes of the other components must decrease to maintain normal pressure. If this does not happen, ICP rises.The process often begins...
20
01:20Myasthenia Gravis: Overview and Treatment
3.7K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
3.7K
01:12Chronic Inflammation: Introduction
41
Chronic inflammation is a prolonged, dysregulated immune response that persists for weeks to years when the inciting stimulus is difficult to eradicate or when self‑antigens drive ongoing reactivity. Morphologically, it is defined by mononuclear cell infiltration, progressive tissue destruction, and concurrent attempts at healing via angiogenesis and fibrosis. Compared with acute inflammation, edema is less prominent while cellular infiltration predominates; triggers include persistent...
41